The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.
about
N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatmentCardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaBiomarkers of acute myocardial infarction in the elderly: troponin and beyondSonographic chest B-lines anticipate elevated B-type natriuretic peptide level, irrespective of ejection fraction.Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF).Diagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderly.Impact of body mass index on plasma N-terminal ProB-type natriuretic peptides in Chinese atrial fibrillation patients without heart failure.Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT TrialRelationship between obesity and N-terminal brain natriuretic Peptide level as a prognostic value after acute myocardial infarction.The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.Prevalence and treatment of heart failure in Swedish nursing homesN-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General PopulationMeta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction.N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial.Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.Serum glutathione S-transferase P1 1 in prediction of cardiac function.All patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Acutely decompensated congestive heart failure: new therapies for an old problem.Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclinesCarfilzomib and the cardiorenal system in myeloma: an endothelial effect?Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgeryThe association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.Association of serum carotenoid levels with N-terminal pro-brain-type natriuretic peptide: a cross-sectional study in Japan.Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: a prospective cohort analytic studyAmino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.Diabetes, left ventricular systolic dysfunction, and chronic heart failure.N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification.Correlation of N-terminal pro-B-type natriuretic peptide levels and cardiac magnetic resonance imaging T2* in patients with β-thalassaemia major.Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction.Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care.B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.Natriuretic peptide-guided therapy: further research required for still-unresolved issues.Markers of left ventricular decompensation in aortic stenosis.Cardiovascular biomarkers and sex: the case for women.The role of cardiac biochemical markers in aortic stenosis.A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting.
P2860
Q24804676-D0A3335B-E9FF-43E0-BE80-96858325B1F4Q26745756-21E1AACE-C2AE-400A-9A3F-BC41C5E81B18Q27005967-C01550B1-087A-412B-8E75-E310039391E2Q30394214-AA2331C9-CE43-447A-A827-B165BD193451Q30908639-C4023DC9-82CE-4843-B85D-1B530BF1F121Q33744529-A78138E2-C4A3-465D-A893-502F82D8607EQ34075408-3B1A4D6B-3EBF-4D41-8B8F-917108E8F2C3Q34304083-33DBE209-84B6-48BC-AA30-11D99AB8F143Q34352658-37BA9631-94AF-4CA1-88D1-E157C4E9D7BBQ34381858-EEB91391-66E2-470F-9D96-B5A66ECEFF66Q34434691-26B9CD6A-C180-4A33-9342-8FFED87025ABQ34477250-466E1035-3492-4992-A1A0-664BEC356206Q34492442-96727085-9B29-4362-A983-703237E17D1DQ34512556-B106C910-D8D9-4A69-962B-B451710427D4Q34753074-43B19656-0AF6-4F65-91C3-7530CF4A2E39Q34871241-9CE70C7A-BB7A-4170-B2FF-9127EDFCBABFQ35584077-96EC5127-06EE-49A0-A96B-65DE481B8254Q35859386-F38C7A5C-C948-4170-8AC0-1B07AFF38699Q35987037-AC503150-DFB2-46DC-B976-91313AAAF26BQ36124913-5FFBCA9B-59E7-4DB1-B381-C5593C0CAD6FQ36266039-6C8A9412-5EFC-4089-B727-CD588EA11D81Q36416745-E2B8AF28-06D1-4B7E-A8EE-1F30AB2439B6Q36548064-A31EEFD8-804E-4A1F-9EB2-58B691A155EFQ36744788-2FC24215-8DCC-423E-BD34-65157CD646F8Q36790405-B7EC4A14-E21A-4D24-AA69-4F18FDA5589EQ36978811-E20E51A0-96F4-43FA-A774-AA012447BEBDQ37004632-1F1538B1-8BF4-4127-AC36-3AEA1F7319BDQ37028637-B161F3EF-4C45-44B8-8787-61C432755DB3Q37108057-564151C3-0603-4E95-B1FD-517453E3D610Q37143034-2B5C1480-3A6B-46A1-B7A0-03C1BB485DEBQ37368214-B97BC5D0-92E3-41AD-BB37-40D6F84C499DQ37417308-2F8F814E-1FC4-498C-94CB-B1D0D1A98221Q37591134-5196F100-63F7-490A-8235-BEE885978B89Q37762320-5F7EB717-8032-44CB-A27E-0A10637330D2Q37833104-A50EF6E6-BA08-4BA9-8AE6-96C7B24195C1Q38099221-2447040C-C9F4-4935-BF10-05AF7055EE1DQ38215381-D4ADDBDE-8EDB-4A0D-97E0-30B297D74D66Q38543356-D8850812-982E-4BFF-93B3-C428415199E0Q38743657-09CD1079-BD28-4E23-A0CA-651950B7131FQ39836686-7B93B603-6DDC-4ED5-8B37-0127294B8B2D
P2860
The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The influence of age, sex and ...... ple of the general population.
@ast
The influence of age, sex and ...... ple of the general population.
@en
type
label
The influence of age, sex and ...... ple of the general population.
@ast
The influence of age, sex and ...... ple of the general population.
@en
prefLabel
The influence of age, sex and ...... ple of the general population.
@ast
The influence of age, sex and ...... ple of the general population.
@en
P2093
P2860
P356
P1433
P1476
The influence of age, sex and ...... mple of the general population
@en
P2093
B A Groenning
F Pedersen
J Trawinski
P R Hildebrandt
P2860
P304
P356
10.1136/HEART.89.7.745
P407
P577
2003-07-01T00:00:00Z